Jennerex raises $21.6 million

Cancer company Jennerex Biotherapeutics Inc. (San Francisco, Calif.) raised $21.6 million in an undisclosed venture round from undisclosed investors. The biotech's Pexa-Vec ( JX-594) is in the Phase I...